Guangzhou-based microsurgery robot developer Deep Surgery has secured “tens of millions” of renminbi in a Pre-Series A financing round led by Wondfo. The funds will be allocated to advancing clinical studies, regulatory submissions, and market expansion both within China and internationally.
FUNZAR Robot Features
Deep Surgery’s flagship product, the FUNZAR microsurgery robot, is equipped with a dual-arm 16-degree-of-freedom robotic arm, a 60x 4K ultra-high-definition 3D digital visual navigation system, modular technology, and sub-micron spatial positioning control. As of March this year, the robot has completed five first-in-man (FIM) trials and entered clinical validation by the end of last year.-Fineline Info & Tech
